Clinical trials: Multiomics
Haematologic Disease, Haematological Malignancy
Integrated Multiomics and Multilevel Characterization of Haematological Disorders and Malignancies
Exploratory multicenter, non-interventional, translational, retrospective and prospective study. All patients with a diagnosis of hematologic disorder or malignancy for whom biological samples and clinical data are available may…
- Trial name
- INTHEMA (NCT04298892)
- Testing
- clinical data and sample collection
- Where
- 26 sites in Italy
- Volunteers
- 2,000 people
- Sponsor
- Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS
Human Immunodeficiency Virus, Chronic Hepatitis b
Gut Microbiome in People Living With HIV and HBV
Building a Microbiome Data Platform and Conducting Clinical Evidence Research in Individuals Infected with the Human Immunodeficiency Virus (HIV) and Hepatitis B virus.
- Conditions
- Human Immunodeficiency Virus, Chronic Hepatitis b, Gut Microbiome
- Trial name
- NCT06130137
- Volunteers
- 200 people
- Sponsor
- Kangbuk Samsung Hospital
Phyllodes Breast Tumor, Artificial Intelligence
AI-Assisted System for Accurate Diagnosis and Prognosis of Breast Phyllodes Tumors
Breast phyllodes tumor (PT) is a rare fibroepithelial tumor, accounting for 1% to 3% of all breast tumors, categorized by the WHO into benign, borderline, and malignant, based on histopathology features such as tumor border…
- Conditions
- Phyllodes Breast Tumor, Artificial Intelligence, Multiomics, Prognostic Cancer Model
- Trial name
- NCT06286267
- Testing
- imaging
- Where
- 4 sites in China
- Volunteers
- 4,000 people
- Sponsor
- Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Back Pain, Low, Degenerative Disc Disease
Protocol for an Analytical Study With Microbiological, Phenotypic, Genotypic and Multiomics Techniques
The study aims to identify metabolites present in intervertebral discs colonized by C. acnes from patients with low back pain and degenerative disc disease, correlating them with their clinical, radiological and demographic…
- Trial name
- NCT05090553
- Testing
- Lumbar Spinal Fusion Surgery, Bacterial culture, Phenotypic and genotypic characterization
- Where
- Brazil
- Volunteers
- 120 people
- Sponsor
- Gaffree & Guinle Universitary Hospital
Phenylketonuria (PKU)
Multiomics Approach in Adult Patients With Phenylketonuria
The GENOPHEN study aims to explore the links between the genome, metabolomic profile, and clinical phenotype in adults with early-treated PKU.
- Trial name
- GENOPHEN (NCT07484945)
- Where
- 15 sites in France
- Volunteers
- 149 people
- Sponsor
- University Hospital, Tours
Colorectal Cancer, Lymph Node
Immune Function of Colorectal Cancer Lymph Nodes
Lymph nodes are very important immune organs in the human body and play an important role in the physiological and pathological activities of the body, especially in anti-tumor immunity.
- Trial name
- NCT06319404
- Volunteers
- 500 people
- Sponsor
- Shanxi Province Cancer Hospital
Severe Traumatic Brain Injury, Severe Brain Injury
The Örebro Severe Traumatic Brain Injury Registry
Traumatic brain injury and other severe brain injuries requiring neurointensive care are associated with high mortality, long-term disability and substantial societal burden.
- Conditions
- Severe Traumatic Brain Injury, Severe Brain Injury, Ischemic Stroke, Intracerebral Hemorrhage
- Trial name
- ÖrSBID (NCT07398274)
- Where
- Sweden
- Volunteers
- 200 people
- Sponsor
- András Zoltán Buki
Headache, Pain, Head
Pain Perception of People Who Are Unable to Have Headache
Headaches are extremely common illnesses with a combined lifetime prevalence of 90-99% in Europe. Despite this high prevalence, there are persons who have never, in their whole life, encountered a headache.
- Conditions
- Headache, Pain, Head, Muscle Tenderness, Healthy
- Trial name
- NCT04217616
- Where
- Denmark
- Volunteers
- 100 people
- Sponsor
- Danish Headache Center
HR Positive/HER-2 Negative Breast Cancer
MRI-Driven Precision Typing and Response Prediction in Luminal Breast Cancer
Luminal breast cancer is characterized by marked heterogeneity, resulting in diverse treatment responses and long-term outcomes.
- Trial name
- NCT07692230
- Where
- China
- Volunteers
- 2,000 people
- Sponsor
- Fudan University
Liver Neoplasm, HBV Infection
Single-cell Multiomics and Spatiotemporal Omics Analyze the Mechanism of Liver Degenerative Disease
The purpose of this observational study is to employ single-cell multi-omics and spatial omics technologies to characterize the spatial and immune structures within the livers of patients with fatty liver, hepatic hemangioma…
- Conditions
- Liver Neoplasm, HBV Infection, Non-alcoholic Fatty Liver Disease NAFLD, Liver Fibrosis
- Trial name
- NCT07265544
- Testing
- Collection of Preoperative Peripheral Blood, Collection of Discarded Liver Tissue During Surgery
- Where
- China
- Volunteers
- 240 people, healthy volunteers welcome
- Sponsor
- Nanfang Hospital, Southern Medical University
Gastric Neoplasms, Gastric Cancer
The EpiGASTRIC/EDGAR Project: New Strategies for the Early Detection and Prevention of Gastric Cancer
This study is a multicenter, prospective cohort study, which are planned to enroll at least 600 patients who diagnosed the primary gastric cancer (GC); around 50 patients with premalignant gastric lesions (PGLs) and early gastric…
- Conditions
- Gastric Neoplasms, Gastric Cancer, Gastric Lesion
- Trial name
- NCT05551416
- Testing
- Identification of risk factors, Characterization of premalignant gastric lesions, Identification of biomarkers
- Where
- 15 sites in Spain
- Volunteers
- 1,200 people
- Sponsor
- EDUARDO ALBENIZ
Sudden Cardiac Death, Exosome Multiomics
Early Evaluation of Exosome Multiomics and Clinical Prognosis in Patients With Sudden Death
Acute coronary syndrome (ACS) is one of the main causes of death. Worldwide, tens of millions of patients are hospitalized for coronary heart disease and ACS every year.
- Conditions
- Sudden Cardiac Death, Exosome Multiomics, Clinical Prognosis
- Trial name
- NCT06856993
- Testing
- standardized medical care of cardiac arrest
- Where
- China
- Volunteers
- 300 people
- Sponsor
- The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Large Vessel Occlusion, Acute Ischemic Stroke
Cerebral Large Vessel Occlusion Stroke Multiomics Biosample Cohort
This multicenter, ambispective cohort study establishes a comprehensive multiomics biobank from five stroke centers, encompassing thrombi, intracranial blood, peripheral arterial/venous blood, and…
- Trial name
- CLOMB (NCT06963489)
- Testing
- Not applicable- observational study
- Where
- 5 sites in China
- Volunteers
- 500 people
- Sponsor
- First Affiliated Hospital of Wannan Medical College
Triple Negative Breast Cancer
Predictive Biomarkers of Response to Checkpoint Inhibitors in Triple Negative Breast Cancer: a Multiomics Platform
Patients with stage II-III Triple negative breast cancer (TNBC) candidates to receive neoadjuvant chemotherapy (NACT) +/- immune checkpoint inhibitor (ICI) will be included.
- Trial name
- PORTRAIT (NCT05916755)
- Testing
- Whole Genome Sequencing, RNA-Sequencing, Microbiome analysis
- Where
- Spain
- Volunteers
- 100 people
- Sponsor
- Vall d'Hebron Institute of Oncology
Rare Diseases, Mitochondrial Diseases
A Multi-Dimensional Model of cAre and transItion for Patients With cOmplex RAre Diseases
Over the past century, the progress in biomedical sciences gave outstanding contributions to the understanding of human conditions, and even curing some of them.
- Conditions
- Rare Diseases, Mitochondrial Diseases, Muscular Dystrophies, Dysmorphic Disorder, Body
- Trial name
- AD-MAIORA (NCT07558213)
- Testing
- Etiopathogenetic diagnosis, Functional diagnosis
- Where
- Italy
- Volunteers
- 136 people
- Sponsor
- Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Rare Cancers, Multiomics
Molecularly Aided Stratification for Tumor Eradication Research
NCT/DKFZ/DKTK MASTER is a prospective, continuously recruiting, multicenter observational study for biology-guided stratification of adults with rare cancers, including rare subtypes of common entities, using comprehensive…
- Trial name
- NCT-MASTER (NCT05852522)
- Where
- Germany
- Volunteers
- 10,000 people
- Sponsor
- German Cancer Research Center
Malignant Tumor, Immunotherapy
A Real-world Study of the Efficacy and Safety of ICIs as First-line Therapy for Advanced Malignancies
In this study, we collected the data of immunohistochemistry, gene detection, image, OS, PFS, Orr, and so on. Secondly, the database of immunotherapy for malignant tumor was established, and the predictive model was constructed…
- Conditions
- Malignant Tumor, Immunotherapy, Artificial Intelligence
- Trial name
- NCT05862259
- Where
- China
- Volunteers
- 120 people
- Sponsor
- Xinqiao Hospital of Chongqing
Headache, Headache Disorders
Multiomics After Cold Pressor Test of People Who Are Unable to Have Headache
Headaches are extremely common illnesses with a combined lifetime prevalence of 90-99% in Europe. Despite this high prevalence, there are persons who have never, in their whole life, encountered a headache.
- Conditions
- Headache, Headache Disorders, Healthy
- Trial name
- NCT04220580
- Testing
- Blood samples
- Where
- Denmark
- Volunteers
- 100 people
- Sponsor
- Danish Headache Center
Ulcerative Colitis
Prediction Model for Response to Biologics and Small Molecular Agent for UC
This prospective observational study is going to develop and validate a prediction model of response to biologic agents and small molecular agents for Korean patients with ulcerative colitis.
- Trial name
- NCT05186623
- Testing
- Vedolizumab, Ustekinumab, or Tofacitinib
- Where
- South Korea
- Volunteers
- 300 people
- Sponsor
- Asan Medical Center
Hepatocellular Carcinoma
Predictive Biomarkers in Patients With Advanced Hepatocellular Carcinoma Treated With Systemic Therapy
Hepatocellular carcinoma (HCC) is the third most common cause of cancer-related deaths worldwide, and HCC is more frequently observed in Asia, including South Korea.
- Trial name
- HCC (NCT05197504)
- Testing
- atezolizumab plus bevacizumab
- Where
- South Korea
- Volunteers
- 166 people
- Sponsor
- CHA University